Laser Acupoints Stimulation on Xerostomia Related Chemoradiotherapy for Head and Neck Cancer Pati… (NCT07029854) | Clinical Trial Compass
Not Yet RecruitingNot Applicable
Laser Acupoints Stimulation on Xerostomia Related Chemoradiotherapy for Head and Neck Cancer Patients
Egypt54 participantsStarted 2025-06-18
Plain-language summary
The purpose of the study is to evaluate to effect of LASER acupoints stimulations on xerostomia patients during chemoradiation therapy after head and neck cancer.
Who can participate
Age range40 Years – 70 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Chemoradiation therapy
* Carcinoma in the head and neck area (NPC)
* Anatomically intact parotid and submandibular glands.
* All patients will be clinically and medically stable when attending the study.
Exclusion Criteria:
* They had a history of xerostomia;
* They had suspected or confirmed physical closure of salivary gland.
* ducts on either side.
* They had known bleeding disorders.
* They Were taking heparin or warfarin.
* They had contraindications for the use of acupuncture at any acupoints.
* They had history of cerebrovascular accident or spinal cord injury.
* They had taken any drug or herbal medicine in the past 30 days that could affect salivary function.
* They were planning to, or ended up taking such a substance during the study.
* Any therapy that may affect treatment.